A new study by UCD's School of Medicine has raised hope that a well known anti-arthritis drug could result in more favourable outcomes for Covid-19 patients.
Six critically ill patients were discharged from hospital within a week after being administered the drug. Today's study by the School of Medicine in UCD, published in the medical journal Respirology, offers great hope.
It suggests that well-known anti-arthritis drug tocilizumab administered at the right time could prevent some of the worst damage from Covid-19 and lead to significantly better outcomes for sick patients.
Professor Paddy Mallon of UCD School of Medicine said: "The particular component that this study shows is this pre-ICU setting, where people are very sick and the use